基本信息
浏览量:3
职业迁徙
个人简介
Prof. Karin Thursky is the director of the National Centre for Antimicrobial Stewardship (NCAS) (based at the University of Melbourne), which is taking a ‘one health’ approach to improving antimicrobial use across all human and animal health sectors; clinical director of the Guidance Group at the Royal Melbourne Hospital (RMH) at the Doherty; Associate Director of Health Services Research and Implementation Science at the Peter MacCallum Cancer Centre and principal fellow in the Department of Medicine at the University of Melbourne and the Sir Peter MacCallum Department of Oncology. She was awarded an MD in 2007, with a thesis titled: "Development of an antibiotic computerised decision-support system for the ICU at RMH".
Prof. Thursky is nationally and internationally recognised as an expert in health services research, especially in antimicrobial stewardship (AMS). As the clinical leader and original developer of the Guidance software (developed at the RMH), she has assisted in the implementation of AMS in over 70 hospitals nationally and has directly contributed to increased workforce capacity for both clinical practice and research in AMS. She is a member of the AMS working party for Australian Commission on Quality and Safety in Healthcare (ACQSHC); and an expert advisor for the national program (AURA) responsible for developing national antimicrobial use and pathogen surveillance, and the Antimicrobial Resistance Strategic Technical Advisory Group for the Commonwealth Department of Health. She leads the development and implementation of the National Antimicrobial Prescribing Survey (NAPS), a program that is a key partner in the AURA system. She has considerable expertise in the development of national consensus guidelines. Her expertise in knowledge translation has led to design, implementation and scaling of several successful projects, including the development and implementation of clinical pathways for sepsis, and ambulatory programs for the management of neutropenic fever. She is leading the implementation stream of the National Centre for Infections in Cancer (NCIC) (based at the Peter MacCallum Cancer Centre) with innovative programs for nurse led antimicrobial stewardship, ambulatory models of care, allergy delabeling, and automated surveillance programs for invasive fungal infection. Her broad experience across the precinct is facilitating new collaborations and will support the emerging opportunities for health services and implementation science research.
Prof. Thursky is nationally and internationally recognised as an expert in health services research, especially in antimicrobial stewardship (AMS). As the clinical leader and original developer of the Guidance software (developed at the RMH), she has assisted in the implementation of AMS in over 70 hospitals nationally and has directly contributed to increased workforce capacity for both clinical practice and research in AMS. She is a member of the AMS working party for Australian Commission on Quality and Safety in Healthcare (ACQSHC); and an expert advisor for the national program (AURA) responsible for developing national antimicrobial use and pathogen surveillance, and the Antimicrobial Resistance Strategic Technical Advisory Group for the Commonwealth Department of Health. She leads the development and implementation of the National Antimicrobial Prescribing Survey (NAPS), a program that is a key partner in the AURA system. She has considerable expertise in the development of national consensus guidelines. Her expertise in knowledge translation has led to design, implementation and scaling of several successful projects, including the development and implementation of clinical pathways for sepsis, and ambulatory programs for the management of neutropenic fever. She is leading the implementation stream of the National Centre for Infections in Cancer (NCIC) (based at the Peter MacCallum Cancer Centre) with innovative programs for nurse led antimicrobial stewardship, ambulatory models of care, allergy delabeling, and automated surveillance programs for invasive fungal infection. Her broad experience across the precinct is facilitating new collaborations and will support the emerging opportunities for health services and implementation science research.
研究兴趣
论文共 299 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Gemma K Reynolds, Marsali Maclean, Edward R Scheffer Cliff,Benjamin W Teh,Karin A Thursky,Monica A Slavin,Mary Ann Anderson,Eliza A. Hawkes
Blood Advances (2024)
Microbiology Australia (2024)
Nurul Adilla Hayat Jamaluddin,Petrick Periyasamy,Chee Lan Lau,Sasheela Ponnampalavanar,Pauline Siew Mei Lai,Ly Sia Loong, Tg Mohd Ikhwan Tg Abu Bakar Sidik,Ramliza Ramli,Toh Leong Tan,Najma Kori,Mei Kuen Yin,Nur Jannah Azman,
Studies in health technology and informatics (2024): 1454-1455
Leukemia & lymphomano. 13 (2023): 1-14
Pem Chuki,Thinley Dorji,Rodney James, Khando Wangchuk,Sonam Yangzom, Yangchen Dema, Sangay Wangchuk, Dorji Wangdi, Tshering Deki, Chandra Limbu, Kuenzang Rangdel Dorji, Sonam Wangda,
JAC-ANTIMICROBIAL RESISTANCEno. 4 (2023): dlad100-dlad100
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2023): 104134-104134
Oxford University Press eBookspp.221-236, (2023)
引用0浏览0引用
0
0
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn